299 related articles for article (PubMed ID: 15103510)
1. Thyroid autoimmunity and dysfunction associated with type I interferon therapy.
Monzani F; Caraccio N; Dardano A; Ferrannini E
Clin Exp Med; 2004 Apr; 3(4):199-210. PubMed ID: 15103510
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.
Pellicano R; Smedile A; Peyre S; Astegiano M; Saracco G; Bonardi R; Rizzetto M
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):55-61. PubMed ID: 15756146
[TBL] [Abstract][Full Text] [Related]
3. Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis.
Dumoulin FL; Leifeld L; Sauerbruch T; Spengler U
Biomed Pharmacother; 1999 Jun; 53(5-6):242-54. PubMed ID: 10424246
[TBL] [Abstract][Full Text] [Related]
4. Association between human leukocyte antigen (HLA) and interferon- induced thyroid diseases in four patients with HCV-related chronic hepatitis.
Labbadia G; Martocchia A; Mammarella A; Paoletti V; Rocco A; Benvenuto R; Antonella P; Rosaria D; Trabace S; Musca A; Falaschi P
Neuro Endocrinol Lett; 2005 Apr; 26(2):109-12. PubMed ID: 15855880
[TBL] [Abstract][Full Text] [Related]
5. The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C.
Watanabe U; Hashimoto E; Hisamitsu T; Obata H; Hayashi N
Am J Gastroenterol; 1994 Mar; 89(3):399-403. PubMed ID: 8122653
[TBL] [Abstract][Full Text] [Related]
6. [Interferon-alpha-induced disorders of thyroid function. A retrospective analysis of the literature and personal experiences].
Weissel M; Templ E; Gisslinger H
Acta Med Austriaca; 1995; 22(1-2):1-5. PubMed ID: 7645363
[TBL] [Abstract][Full Text] [Related]
7. [Autoimmune thyroid disease induced by interferon therapy].
Murakami M; Kakizaki S; Takayama H; Takagi H; Mori M
Nihon Rinsho; 1999 Aug; 57(8):1779-83. PubMed ID: 10483250
[TBL] [Abstract][Full Text] [Related]
8. [Autoimmune thyroid disorders and reproductive failures].
Todorova-Ananieva K
Akush Ginekol (Sofiia); 2009; 48 Suppl 2():26-30. PubMed ID: 20380094
[TBL] [Abstract][Full Text] [Related]
9. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification.
Mandac JC; Chaudhry S; Sherman KE; Tomer Y
Hepatology; 2006 Apr; 43(4):661-72. PubMed ID: 16557537
[TBL] [Abstract][Full Text] [Related]
10. Immune-endocrine interactions in autoimmune thyroid diseases.
Klecha AJ; Barreiro Arcos ML; Frick L; Genaro AM; Cremaschi G
Neuroimmunomodulation; 2008; 15(1):68-75. PubMed ID: 18667802
[TBL] [Abstract][Full Text] [Related]
11. [Interferon therapy in chronic viral hepatitis; an autoimmunity dilemma].
Gutkowski K; Gutkowska D; Bilkiewicz T
Przegl Lek; 2007; 64(3):148-52. PubMed ID: 17941466
[TBL] [Abstract][Full Text] [Related]
12. Development of autoimmune thyroid diseases during long-term treatment of hematological malignancies with alpha-interferons.
Silvestri F; Virgolini L; Mazzolini A; Bertolissi F; Russo D; Fanin R; Baccarani M
Haematologica; 1994; 79(4):367-70. PubMed ID: 7806093
[TBL] [Abstract][Full Text] [Related]
13. Clinical and laboratory aspects of thyroid autoantibodies.
Sinclair D
Ann Clin Biochem; 2006 May; 43(Pt 3):173-83. PubMed ID: 16704751
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy-induced thyroid disorders.
Jereczek-Fossa BA; Alterio D; Jassem J; Gibelli B; Tradati N; Orecchia R
Cancer Treat Rev; 2004 Jun; 30(4):369-84. PubMed ID: 15145511
[TBL] [Abstract][Full Text] [Related]
15. [Thyroid dysfunctions in patients with viral hepatitis treated with interferon-alpha].
Földes I; Dávid K; Horváth G; Osztrogonácz H; Jankovics K; Tolvaj G
Orv Hetil; 2004 Jun; 145(23):1211-6. PubMed ID: 15264588
[TBL] [Abstract][Full Text] [Related]
16. [Subclinical thyroid disease--should we treat, should we screen for it?].
Trbojević B
Srp Arh Celok Lek; 2003; 131(11-12):467-73. PubMed ID: 15114790
[TBL] [Abstract][Full Text] [Related]
17. Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy.
Custro N; Montalto G; Scafidi V; Soresi M; Gallo S; Tripi S; Notarbartolo A
J Endocrinol Invest; 1997; 20(7):374-80. PubMed ID: 9309534
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis C virus infection and thyroid diseases].
Broussolle C; Steineur MP; Bailly F; Zoulim F; Trépo C
Rev Med Interne; 1999 Sep; 20(9):766-73. PubMed ID: 10522298
[TBL] [Abstract][Full Text] [Related]
19. Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study.
Mazziotti G; Sorvillo F; Stornaiuolo G; Rotondi M; Morisco F; Ruberto M; Cioffi M; Amato G; Caporaso N; Gaeta GB; Carella C
J Endocrinol Invest; 2002; 25(7):624-30. PubMed ID: 12150338
[TBL] [Abstract][Full Text] [Related]
20. [Thyroid function and thyroid autoimmunity at the late pregnancy: data from 664 pregnant women].
Guan HX; Li CY; Li YS; Fan CL; Teng Y; Ouyang YH; Cong Q; Teng WP
Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):529-32. PubMed ID: 17083836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
